Outset Medical (OM) Gross Margin (2019 - 2026)

Outset Medical (OM) has 8 years of Gross Margin data on file, last reported at 43.41% in Q1 2026.

• On a quarterly basis, Gross Margin rose 621.0% year-over-year to 43.41% in Q1 2026; TTM through Mar 2026 was 40.64%, a 471.0% increase from a year earlier, with the FY2025 full-year figure at 39.13%, up 521.0% from the prior year.
• Gross Margin for Q1 2026 stood at 43.41%, up from 42.36% in the prior quarter.
• Over the last five years, Gross Margin for OM reached as high as 43.41% in Q1 2026 and fell as low as 14.54% in Q1 2022.
• Historically, Gross Margin has averaged 28.64% across 5 years, with a median of 29.16% in 2024.
• Across the five-year window, Gross Margin surged 1434 bps in 2024 and surged 205 bps in 2025, its largest moves.
• Year by year, Gross Margin stood at 16.47% in 2022, then soared by 53 bps to 25.28% in 2023, then jumped by 44 bps to 36.47% in 2024, then rose by 16 bps to 42.36% in 2025, then advanced by 2 bps to 43.41% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 43.41% in Q1 2026, 42.36% in Q4 2025, and 39.38% in Q3 2025.